International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Regulatory Issues for the Use of Bulk Drugs in Veterinary Compounding

Author(s): Chan Debora Schotik

Issue: Mar/Apr 2001 - Compounding for Animals
View All Articles in Issue

Page(s): 97-100

Regulatory Issues for the Use of Bulk Drugs in Veterinary Compounding Page 1

Regulatory Issues for the Use of Bulk Drugs in Veterinary Compounding Page 2

Regulatory Issues for the Use of Bulk Drugs in Veterinary Compounding Page 3

Regulatory Issues for the Use of Bulk Drugs in Veterinary Compounding Page 4

Download in electronic PDF format for $75

Abstract: Regulations for the use of bulk drugs in animals are unclear. In this article, the author focuses on US food and drug regulations, use of bulk drugs to compound for humans and animals, US Food and Drug Administration regulations governing the use of bulk drugs, and regulatory actions. Tables provide a list of proposed bulk drugs suitable for use in compounding for humans, drug products not to be used in compounding and drugs prohibited for extralabel use in food-producing animals.

Related Keywords: bulk drugs, food and drug regulations, medications for animals, regulatory issues, use of bulk drugs, veterinary compounding

Related Categories: LEGAL, VETERINARY, FDA

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Veterinary Transdermal Medications: A to Z Davidson Gigi S	Mar/Apr 2003 Pg. 106-113
Regulatory Issues for the Use of Bulk Drugs in Veterinary Compounding Chan Debora Schotik	Mar/Apr 2001 Pg. 97-100
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances Miller David G	Jul/Aug 2015 Pg. 303-305
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Allen Loyd V Jr	Sep/Oct 2017 Pg. 356
Regulatory and Operational Issues of Founding a Compounding Pharmacy Smith Lisa K	Nov/Dec 2002 Pg. 434-437
Drugs Banned for Use in Food Animals: An Explanation Davidson Gigi S	Mar/Apr 2001 Pg. 101-103
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Allen Loyd V Jr	Jul/Aug 2016 Pg. 351 View Sample
Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA Cabaleiro Joe	Sep/Oct 2021 Pg. 358-362
TPN Bulk Compounding from Bulk Drug Substances Chamallas Stanley N	Sep/Oct 1998 Pg. 347-349
When to Compound Medications for Veterinary Patients Forsythe Lauren Eichstadt	Jan/Feb 2017 Pg. 19-21
Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs Dillon L R	Jan/Feb 2020 Pg. 30-36
Combating Cardiovascular Disease with Compounded Medications -- Part 2: Clinical and Compounding Issues for Antihypertensive Drugs Harrington Catherine A, Cauffield Jacintha	May/Jun 2005 Pg. 201-205
Final Guidance for Pharmacy Compounding of Human Drug Products Under Section 503A Blankenship Cynthia E	Sep/Oct 2014 Pg. 379-380
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs Allen Loyd V Jr	Nov/Dec 2015 Pg. 487-488
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis Lyon Joanna	Nov/Dec 2012 Pg. 456-460
U.S. Food and Drug Administration List of Drugs NOT to be Used in Compounded Medications for Humans (The Negative List)	Nov/Dec 2016 Pg. 457-458
Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 11: Drug Tastes: Innate, Induced, and Improved Allen Loyd V Jr	Sep/Oct 2021 Pg. 396-400
PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse Williams LaVonn A	Nov/Dec 2011 Pg. 526-527
The U.S. Food and Drug Administration Takes Aim at Compounded Thyroid Hormone Brunner Scott	Jan/Feb 2023 Pg. 22-23
Return to Top